Miravant Medical Technologies Inc.
MRVT
$0.00
$0.000.00%
OTC PK
| 09/30/2005 | 06/30/2005 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -16.03% | -20.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -31.86% | 33.95% | |||
| Operating Income | 31.86% | -33.95% | |||
| Income Before Tax | 28.66% | -31.67% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 28.66% | -31.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 28.66% | -31.67% | |||
| EBIT | 31.86% | -33.95% | |||
| EBITDA | 33.04% | -34.56% | |||
| EPS Basic | 29.14% | -30.58% | |||
| Normalized Basic EPS | 29.15% | -29.75% | |||
| EPS Diluted | 29.14% | -30.58% | |||
| Normalized Diluted EPS | 29.15% | -29.75% | |||
| Average Basic Shares Outstanding | 0.69% | 0.85% | |||
| Average Diluted Shares Outstanding | 0.69% | 0.85% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||